Health & Environmental Research Online (HERO)


Print Feedback Export to File
6321794 
Journal Article 
Review 
Surface impact on nanoparticle-based magnetic resonance imaging contrast agents 
Zhang, W; Liu, L; Chen, H; Hu, K; Delahunty, I; Gao, S; Xie, J 
2018 
1 
Theranostics
ISSN: 1838-7640 
8 
9 
2521-2548 
English 
29721097 
WOS:000429880400008 
Magnetic resonance imaging (MRI) is one of the most widely used diagnostic tools in the clinic. To improve imaging quality, MRI contrast agents, which can modulate local T1 and T2 relaxation times, are often injected prior to or during MRI scans. However, clinically used contrast agents, including Gd3+-based chelates and iron oxide nanoparticles (IONPs), afford mediocre contrast abilities. To address this issue, there has been extensive research on developing alternative MRI contrast agents with superior r1 and r2 relaxivities. These efforts are facilitated by the fast progress in nanotechnology, which allows for preparation of magnetic nanoparticles (NPs) with varied size, shape, crystallinity, and composition. Studies suggest that surface coatings can also largely affect T1 and T2 relaxations and can be tailored in favor of a high r1 or r2. However, the surface impact of NPs has been less emphasized. Herein, we review recent progress on developing NP-based T1 and T2 contrast agents, with a focus on the surface impact.